Intracavitary Interleukin-2 (IL-2) and Lymphokine-Activated Killer (LAK) Cell Therapy for Malignant Gliomas.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interleukin-2 (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 09 Feb 2009 Biomarkers information updated
- 15 Sep 2005 New trial record.